Onsdag 5 Februari | 08:50:06 Europe / Stockholm

Bifogade filer

Kalender

Tid*
2026-01-10 N/A Årsstämma
2025-11-30 N/A Bokslutskommuniké 2025
2025-07-17 08:30 Kvartalsrapport 2025-Q3
2025-04-17 08:30 Kvartalsrapport 2025-Q2
2025-02-19 08:30 Kvartalsrapport 2025-Q1
2025-02-03 - X-dag ordinarie utdelning CSMED 0.00 DKK
2025-01-31 - Årsstämma
2025-01-09 - 15-6 2025
2024-11-30 - Bokslutskommuniké 2024
2024-11-12 - Extra Bolagsstämma 2024
2024-08-15 - Kvartalsrapport 2024-Q3
2024-05-30 - Årsstämma
2024-05-17 - Kvartalsrapport 2024-Q2
2024-03-01 - X-dag ordinarie utdelning CSMED 0.00 DKK
2024-02-14 - Bokslutskommuniké 2023
2024-02-14 - Kvartalsrapport 2024-Q1
2023-12-15 - X-dag ordinarie utdelning CSMED 0.00 DKK
2023-07-18 - Kvartalsrapport 2023-Q3
2023-05-17 - Kvartalsrapport 2023-Q2
2023-04-14 - Extra Bolagsstämma 2023
2023-02-17 - Kvartalsrapport 2023-Q1
2023-02-14 - Årsstämma
2023-02-10 - X-dag ordinarie utdelning CSMED 0.00 DKK
2022-11-18 - Bokslutskommuniké 2022
2022-08-13 - Kvartalsrapport 2022-Q3
2022-05-20 - Kvartalsrapport 2022-Q2
2022-02-18 - Kvartalsrapport 2022-Q1
2021-12-10 - X-dag ordinarie utdelning CSMED 0.00 DKK
2021-12-09 - Årsstämma
2021-11-18 - Bokslutskommuniké 2021

Beskrivning

LandDanmark
ListaSpotlight DK
SektorHälsovård
IndustriLäkemedel & Handel
CS Medica är ett danskt medicintekniskt bolag, dedikerat till läkemedelsforskning, utveckling, tillverkning och global kommersialisering. Bolaget blandar vetenskap och natur för att förbättra patienters liv med cannabinoidterapier för smärtlindring, och för att hantera autoimmuna och stressrelaterade symtom. Globalt erbjuder CS Medica CBD-behandlingar över disk (OTC), inklusive patenterade medicinska produkter, MHRA och MDR-registrerade artiklar, under varumärket CANNASEN® eller med egen märkning.
2022-08-24 08:45:00

CS MEDICA A/S's ("CS MEDICA" or the "Company") long-awaited breakthrough in the Danish pharmacy world is now a reality, as they close agreements with two out of the three leading pharmacy chains in Denmark.  With this agreement the Company get access to 400 pharmacies in Denmark, with shelf space as well as online availability for the full CANNASEN® CBD product line.

Lone Henriksen, CEO CS MEDICA A/S comments

"We are proud to announce, that we finally made it to the pharmacies, with agreements signed with two of the three leading pharmacy chains in Denmark.  We will use and optimize this new position in the market by accelerating our listings and built brand stores on the growing players within the online pharmacy channel."

CS MEDICA today finalized the cooperation agreement, in voluntary assortment, with two out of the three leading pharmacy chains in Denmark, Pharmaplus and Apotekeren. 

Pharmaplus with its 27 main pharmacies and 89 subsidiary pharmacies have agreed to list the full CANNASEN® CBD product line both instore and on their web shop.

Apotekeren with its 102 main pharmacies and 182 subsidiary pharmacies, have agreed to start with the following 4 CANNASEN® CBD products instore and the full product line on their web shop. 

CANNASEN® CBD Psoriasis Gel
CANNASEN® CBD Psoriasis Lotion
CANNASEN® CBD Arthritis Gel
CANNASEN® CBD Anti hair loss Serum

The Danish pharmacists have been a milestone in CS MEDICA's go-to-market strategy, with their innovative CBD products supported with clinical trials, now launching into the Danish market.

To support the training of the pharmacies in medical device products with CBD, CS MEDICA has engaged a sales consultant with more than 20 years of experience within the pharmacy industry.